Icotinib

  • Catalog number
    B3003-5
  • Price
    Please ask
  • Size
    5 mg
  • Alternative_name
    BPI-2009; BPI-2009H; N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine; Conmana; (3-Ethynyl-phenyl)(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diazacyclododeca[b]naphthalen-4-yl)-amine; N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine
  • Description
    Icotininb is a potent epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with an IC₅₀ of 5 nM. It blocks EGFR-mediated intracellular tyrosine phosphorylation IC₅₀ of 45 nM in the human epidermoid carcinoma A431 cell line and inhibits tumor cell proliferation. Icotinib shows potent dose-dependent antitumor effects in nude mice carrying a variety of human tumor-derived xenografts. The drug is well tolerated at doses up to 120 mg/kg/day in mice without mortality or significant body weight loss during the treatment.
  • CAS Number
    610798-31-7
  • Structure Available
    1
  • Molecular Formula
    C₂₂H₂₁N₃O₄
  • Molecular Weight
    391.4
  • Cell Permeable
    1
  • Purity
    >99%
  • Solubilities
    ~75 mg/ml in DMSO
  • Handling
    Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
  • Tag Line
    A potent EGFR inhibitor
  • Storage Condition
    -20ºC
  • Shipping Condition
    RT
  • Shelf Life
    36 months
  • MDL Number
    MFCD22124501
  • PubChem CID
    22024915
  • SMILES
    C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4
  • InChi
    InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)
  • InChi Key
    QQLKULDARVNMAL-UHFFFAOYSA-N
  • MSDS Available
    1
  • Gene target
  • Short name
    Icotinib
  • Alternative name
    Icotinib
Product images
Similar products
Filters
Contact
Chat with gentaur.com employee